Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Normark

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
JCI Insight|May 8, 2024
Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humansFredrika Hellgren, Anja Rosdahl, Rodrigo Arcoverde Cerveira, et al.
Frontiers in Public Health|February 23, 2023
High prevalence of persistent symptoms and reduced health-related quality of life 6 months after COVID-19Irma Ahmad, Alicia Edin, Christoffer Granvik, et al.
Mbio|September 20, 2024
SARS-CoV-2 infection induces hyaluronan production <i>in vitro</i> and hyaluronan levels in COVID-19 patients relate to morbidity and long-term lung impairment: a prospective cohort studyUrban Hellman, Ebba Rosendal, Joakim Lehrstrand, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological assessment of SARS-CoV-2 exposure in northern Sweden by the use of at-home sampling to meet geographical challenges in rural regionsJulia Wigren Byström, Linnea Vikström, Ebba Rosendal, et al.
The Lancet Regional Health. Europe|June 26, 2023
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational studyLinnea Vikström, Peter Fjällström, Yong-Dae Gwon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 30, 2023
At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort studyJulia Wigren Byström, Linnea Vikström, Ebba Rosendal, et al.
JCI Insight|October 19, 2021
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccinationAlberto Cagigi, Meng Yu, Björn Österberg, et al.
The Lancet. Digital Health|September 3, 2022
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort studyJan A Staessen, Ralph Wendt, Yu-Ling Yu, et al.
Nature Medicine|February 26, 2021
A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severitySirui Zhou, Guillaume Butler-Laporte, Tomoko Nakanishi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 19, 2023
Tuberculosis incidence in foreign-born people residing in European countries in 2020Anca Vasiliu, Niklas Köhler, Ekkehardt Altpeter, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
JCI Insight|May 8, 2024
Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humansFredrika Hellgren, Anja Rosdahl, Rodrigo Arcoverde Cerveira, et al.
Frontiers in Public Health|February 23, 2023
High prevalence of persistent symptoms and reduced health-related quality of life 6 months after COVID-19Irma Ahmad, Alicia Edin, Christoffer Granvik, et al.
Mbio|September 20, 2024
SARS-CoV-2 infection induces hyaluronan production <i>in vitro</i> and hyaluronan levels in COVID-19 patients relate to morbidity and long-term lung impairment: a prospective cohort studyUrban Hellman, Ebba Rosendal, Joakim Lehrstrand, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological assessment of SARS-CoV-2 exposure in northern Sweden by the use of at-home sampling to meet geographical challenges in rural regionsJulia Wigren Byström, Linnea Vikström, Ebba Rosendal, et al.
The Lancet Regional Health. Europe|June 26, 2023
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational studyLinnea Vikström, Peter Fjällström, Yong-Dae Gwon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 30, 2023
At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort studyJulia Wigren Byström, Linnea Vikström, Ebba Rosendal, et al.
JCI Insight|October 19, 2021
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccinationAlberto Cagigi, Meng Yu, Björn Österberg, et al.
The Lancet. Digital Health|September 3, 2022
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort studyJan A Staessen, Ralph Wendt, Yu-Ling Yu, et al.
Nature Medicine|February 26, 2021
A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severitySirui Zhou, Guillaume Butler-Laporte, Tomoko Nakanishi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 19, 2023
Tuberculosis incidence in foreign-born people residing in European countries in 2020Anca Vasiliu, Niklas Köhler, Ekkehardt Altpeter, et al.
Pageof 5